Gouynou, C. ., Pouillon, L. ., Rousseau, H. ., Zallot, C. ., Baumann, C. ., & Peyrin-Biroulet, L. . (2018). Early changes in the pharmacokinetic profile of vedolizumab-treated patients with IBD may predict response after dose optimisation. Gut. https://doi.org/10.1136/gutjnl-2017-315766 (Original work published 2018)
L Peyrin-Biroulet
First name:
L
Last name:
Peyrin-Biroulet
Bonovas, S. ., Lytras, T. ., Nikolopoulos, G. ., Peyrin-Biroulet, L. ., & Danese, S. . (2018). Editorial: tofacitinib and biologics for moderate-to-severe ulcerative colitis-what is best in class? Authors’ reply. Alimentary Pharmacology & Therapeutics, 47(4), 540-541. https://doi.org/10.1111/apt.14486
Allocca, M. ., Gilardi, D. ., Fiorino, G. ., Furfaro, F. ., Peyrin-Biroulet, L. ., & Danese, S. . (2018). Sexual and reproductive issues and inflammatory bowel disease: a neglected topic in men. European Journal of Gastroenterology & Hepatology. https://doi.org/10.1097/MEG.0000000000001074 (Original work published 2018)
Olivera, P. ., Sandborn, W. ., Panés, J. ., Baumann, C. ., D’Haens, G. ., Vermeire, S. ., … Peyrin-Biroulet, L. . (2018). Physicians’ perspective on the clinical meaningfulness of inflammatory bowel disease trial results: an International Organization for the Study of Inflammatory Bowel Disease (IOIBD) survey. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.14514 (Original work published 2018)
Loubet, P. ., Verger, P. ., , Peyrin-Biroulet, L. ., & Launay, O. . (2018). Pneumococcal and influenza vaccine uptake in adults with inflammatory bowel disease in France: Results from a web-based study. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. https://doi.org/10.1016/j.dld.2017.12.027 (Original work published 2018)
Gabbiadini, R. ., Zacharopoulou, E. ., Furfaro, F. ., , Zilli, A. ., Gilardi, D. ., … Allocca, M. . Application of Ultrasound Elastography for Assessing Intestinal Fibrosis in Inflammatory Bowel Disease: Fiction or Reality?. Current Drug Targets, 22(3), 347-355. https://doi.org/10.2174/1389450121666201119142919 (Original work published 2021)